Clinical TrialPTSDKetamineCompleted

Ketamine Infusion Therapy for the Treatment of PTSD in Paramedics

Observational prospective cohort (n=7) evaluating change on psychological screening tools before, after, and 30 days following a six-infusion ketamine series in paramedics with work-related PTSD.

Target Enrollment
7 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

Paramedics with PTSD related to prehospital work receive a series of six one-hour ketamine hydrochloride infusions over three weeks; assessments occur before treatment, after the series, and 30 days post-treatment to assess durability.

Outcome measures include PHQ-9, PCL-5, AUDIT, BAI administered pre/post/30 days, plus RMEQ-30 and a single-item experiential impact survey after the infusion series; study is a prospective cohort (non-probability sample).

Study Protocol

Preparation

sessions

Dosing

6 sessions
60 min each

Integration

sessions

Study Arms & Interventions

Ketamine infusions

experimental

Six one-hour ketamine infusions administered over three weeks.

Interventions

  • Ketamine
    via IVseries (six infusions over 3 weeks)6 doses total

    Six one-hour IV infusions; dose per site protocol (not specified in registry fragment).

Participants

Ages
1875
Sexes
Male & Female

Inclusion Criteria

  • Inclusion Criteria:
  • Must have worked as a paramedic (EMT-P) on a 911 prehospital service for at least five years.
  • Must be diagnosed with post traumatic stress disorder that happened as a result of working as a paramedic
  • Diagnosis must have been made by a mental health professional
  • The symptoms of PTSD must be having a significant adverse effect on the subject's life
  • Subjects must be able to speak and read English

Exclusion Criteria

  • Exclusion Criteria:
  • Currently participating in another PTSD treatment program and/or research study
  • Diagnosis of psychosis
  • Uncontrolled hypertension or a history of heart failure

Study Details

  • Status
    Completed
  • Phase
    Phase NA
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment7 participants
  • Timeline
    Start: 2019-05-02
    End: 2021-02-22
  • Compound
  • Topic

Locations

KlarisanaSan Antonio, Texas, United States

Your Library